First Time Loading...

Cellmid Ltd
ASX:CDY

Watchlist Manager
Cellmid Ltd Logo
Cellmid Ltd
ASX:CDY
Watchlist
Price: 0.054 AUD 8% Market Closed
Updated: Apr 24, 2024

Intrinsic Value

CDY price has not been updated for more than 11 months. This may indicate that the stock has been delisted.
CDY doesn't have a meaningful market cap.

Cellmid Ltd. operates as a biotechnology company, which engages in the development and marketing of therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of... [ Read More ]

There is not enough data to reliably calculate the intrinsic value of CDY.

Key Points:
CDY Intrinsic Value
Base Case
Not Available
Base Case Scenario

Fundamental Analysis

Beta
Ask me anything about
Cellmid Ltd

Provide an overview of the primary business activities
of Cellmid Ltd.

What unique competitive advantages
does Cellmid Ltd hold over its rivals?

What risks and challenges
does Cellmid Ltd face in the near future?

Show all valuation multiples
for Cellmid Ltd.

Provide P/S
for Cellmid Ltd.

Provide P/E
for Cellmid Ltd.

Provide P/OCF
for Cellmid Ltd.

Provide P/FCFE
for Cellmid Ltd.

Provide P/B
for Cellmid Ltd.

Provide EV/S
for Cellmid Ltd.

Provide EV/GP
for Cellmid Ltd.

Provide EV/EBITDA
for Cellmid Ltd.

Provide EV/EBIT
for Cellmid Ltd.

Provide EV/OCF
for Cellmid Ltd.

Provide EV/FCFF
for Cellmid Ltd.

Provide EV/IC
for Cellmid Ltd.

Compare the intrinsic valuations
of Cellmid Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Cellmid Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Cellmid Ltd compared to its peers.

Compare the P/E ratios
of Cellmid Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Cellmid Ltd with its peers.

Analyze the financial leverage
of Cellmid Ltd compared to its main competitors.

Show all profitability ratios
for Cellmid Ltd.

Provide ROE
for Cellmid Ltd.

Provide ROA
for Cellmid Ltd.

Provide ROIC
for Cellmid Ltd.

Provide ROCE
for Cellmid Ltd.

Provide Gross Margin
for Cellmid Ltd.

Provide Operating Margin
for Cellmid Ltd.

Provide Net Margin
for Cellmid Ltd.

Provide FCF Margin
for Cellmid Ltd.

Show all solvency ratios
for Cellmid Ltd.

Provide D/E Ratio
for Cellmid Ltd.

Provide D/A Ratio
for Cellmid Ltd.

Provide Interest Coverage Ratio
for Cellmid Ltd.

Provide Altman Z-Score Ratio
for Cellmid Ltd.

Provide Quick Ratio
for Cellmid Ltd.

Provide Current Ratio
for Cellmid Ltd.

Provide Cash Ratio
for Cellmid Ltd.

What is the historical Revenue growth
over the last 5 years for Cellmid Ltd?

What is the historical Net Income growth
over the last 5 years for Cellmid Ltd?

What is the current Free Cash Flow
of Cellmid Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Cellmid Ltd.

Financials

Balance Sheet Decomposition
Cellmid Ltd

Current Assets 11.3m
Cash & Short-Term Investments 6.7m
Receivables 1.8m
Other Current Assets 2.8m
Non-Current Assets 2m
PP&E 579.9k
Intangibles 1.4m
Current Liabilities 1.9m
Accounts Payable 682.2k
Accrued Liabilities 261.7k
Other Current Liabilities 971.3k
Non-Current Liabilities 943.5k
Long-Term Debt 844k
Other Non-Current Liabilities 99.5k
Efficiency

Earnings Waterfall
Cellmid Ltd

Revenue
5.8m AUD
Cost of Revenue
-2.1m AUD
Gross Profit
3.7m AUD
Operating Expenses
-7.7m AUD
Operating Income
-4m AUD
Other Expenses
620.2k AUD
Net Income
-3.4m AUD

Free Cash Flow Analysis
Cellmid Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

CDY Profitability Score
Profitability Due Diligence

Cellmid Ltd's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

26/100
Profitability
Score

Cellmid Ltd's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

CDY Solvency Score
Solvency Due Diligence

Cellmid Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
67/100
Solvency
Score

Cellmid Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CDY Price Targets Summary
Cellmid Ltd

There are no price targets for CDY.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

CDY Price
Cellmid Ltd

1M 1M
-
6M 6M
-
1Y 1Y
-
3Y 3Y
-21%
5Y 5Y
-75%
10Y 10Y
-99%
Annual Price Range
0.054
52w Low
N/A
52w High
N/A
Price Metrics
Average Annual Return -22.7%
Standard Deviation of Annual Returns 35.4%
Max Drawdown -86%
Shares Statistics
Market Capitalization 10.9m AUD
Shares Outstanding 220 216 992
Percentage of Shares Shorted
N/A

CDY Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Cellmid Ltd Logo
Cellmid Ltd

Country

Australia

Industry

Consumer products

Market Cap

10.9m AUD

Dividend Yield

0%

Description

Cellmid Ltd. operates as a biotechnology company, which engages in the development and marketing of therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-12-09. The firm is specialized in developing anti-aging solutions. The firm operates through two segments: Diagnostics and Consumer Health. The firm is engaged in the research and development of diagnostic and therapeutic products for the management of diseases, such as cancer and various chronic inflammatory conditions by targeting midkine. The company is also engaged in the development and sale of over the counter (OTC) and cosmetic products for hair loss and anti-aging hair care through its FGF5 inhibitor technology. The company has developed a range of products under the evolis, evolis Professional, Lexilis Hybrid, Jo-JuRED and Lexilis BLACK brands.

Contact

NEW SOUTH WALES
Sydney
Se 204 L 2, 55 Clarence Street
+61292216830
http://www.cellmid.com.au/

IPO

2005-12-09

Employees

-

Officers

CEO, MD & Exec. Director
Ms. Maria Halasz BSc, MBA
Managing Director of Advangen Japan
Ms. Teruko Fujii
Group Financial Controller
Mr. Matthew Dudek
Chief Operating Officer
Mr. Dominic Burg
Head of R&D
Dr. Graham Robertson
Global Head of Marketing Advangen Pty Ltd
Ms. Trish Frelan
Show More
Company Sec.
Mr. Lee Tamplin B.A.
Show Less

See Also

Discover More